 Caroline Dias
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 3 | 2025 | 77 | 2.530 |
Why?
| | DNA Copy Number Variations | 3 | 2024 | 182 | 1.610 |
Why?
| | Autistic Disorder | 4 | 2024 | 204 | 1.580 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 177 | 1.120 |
Why?
| | Fragile X Mental Retardation Protein | 2 | 2024 | 50 | 1.100 |
Why?
| | Mosaicism | 2 | 2025 | 73 | 1.050 |
Why?
| | Myotonic Dystrophy | 1 | 2025 | 10 | 0.930 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2024 | 56 | 0.890 |
Why?
| | Nucleus Accumbens | 5 | 2019 | 138 | 0.890 |
Why?
| | Huntington Disease | 1 | 2025 | 57 | 0.880 |
Why?
| | Microsatellite Repeats | 1 | 2025 | 168 | 0.870 |
Why?
| | Genetic Predisposition to Disease | 4 | 2021 | 2419 | 0.790 |
Why?
| | Mutation, Missense | 3 | 2021 | 338 | 0.740 |
Why?
| | Cell Nucleus | 1 | 2024 | 617 | 0.730 |
Why?
| | Transcription Factor 7-Like 2 Protein | 1 | 2021 | 23 | 0.720 |
Why?
| | Synapses | 1 | 2024 | 427 | 0.690 |
Why?
| | Cocaine | 4 | 2017 | 166 | 0.660 |
Why?
| | Netrins | 1 | 2019 | 1 | 0.650 |
Why?
| | GPI-Linked Proteins | 1 | 2019 | 72 | 0.630 |
Why?
| | Genetic Association Studies | 1 | 2021 | 377 | 0.620 |
Why?
| | Brain | 3 | 2024 | 2675 | 0.560 |
Why?
| | Genetic Variation | 1 | 2021 | 988 | 0.490 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2015 | 56 | 0.460 |
Why?
| | Dendritic Spines | 1 | 2015 | 65 | 0.450 |
Why?
| | Trinucleotide Repeat Expansion | 2 | 2024 | 29 | 0.440 |
Why?
| | Phosphoproteins | 1 | 2015 | 338 | 0.400 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2015 | 429 | 0.380 |
Why?
| | Intellectual Disability | 2 | 2024 | 165 | 0.340 |
Why?
| | Autism Spectrum Disorder | 2 | 2024 | 396 | 0.270 |
Why?
| | Epigenesis, Genetic | 3 | 2025 | 659 | 0.260 |
Why?
| | Cocaine-Related Disorders | 3 | 2017 | 113 | 0.260 |
Why?
| | Phenotype | 3 | 2025 | 3202 | 0.250 |
Why?
| | Chromatin Assembly and Disassembly | 2 | 2017 | 104 | 0.240 |
Why?
| | Chromosome Duplication | 1 | 2024 | 5 | 0.230 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 311 | 0.220 |
Why?
| | Chromosome Aberrations | 1 | 2024 | 155 | 0.210 |
Why?
| | Trisomy | 1 | 2024 | 82 | 0.210 |
Why?
| | Ataxia | 1 | 2023 | 44 | 0.210 |
Why?
| | Transcription Factors | 3 | 2022 | 1720 | 0.200 |
Why?
| | Tremor | 1 | 2023 | 65 | 0.200 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 452 | 0.190 |
Why?
| | Exome | 2 | 2020 | 231 | 0.180 |
Why?
| | Mutagenesis | 1 | 2022 | 182 | 0.180 |
Why?
| | Astrocytes | 1 | 2023 | 210 | 0.180 |
Why?
| | Humans | 16 | 2025 | 137294 | 0.180 |
Why?
| | Open Reading Frames | 1 | 2021 | 119 | 0.170 |
Why?
| | Stress, Psychological | 3 | 2019 | 1101 | 0.170 |
Why?
| | Syndrome | 1 | 2021 | 357 | 0.170 |
Why?
| | Chromatin | 1 | 2024 | 519 | 0.170 |
Why?
| | Neurobiology | 1 | 2020 | 15 | 0.160 |
Why?
| | Software | 1 | 2025 | 667 | 0.160 |
Why?
| | Enkephalins | 1 | 2019 | 20 | 0.160 |
Why?
| | Dominance-Subordination | 1 | 2019 | 16 | 0.160 |
Why?
| | Neurons | 3 | 2024 | 1588 | 0.160 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2017 | 126 | 0.160 |
Why?
| | Homozygote | 1 | 2019 | 203 | 0.150 |
Why?
| | Child | 4 | 2024 | 21999 | 0.150 |
Why?
| | Pedigree | 1 | 2019 | 514 | 0.150 |
Why?
| | Alleles | 1 | 2021 | 892 | 0.140 |
Why?
| | Male | 10 | 2024 | 67560 | 0.130 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 5753 | 0.130 |
Why?
| | Cerebral Cortex | 1 | 2020 | 434 | 0.130 |
Why?
| | Animals | 9 | 2025 | 36862 | 0.130 |
Why?
| | Behavior, Animal | 1 | 2019 | 497 | 0.120 |
Why?
| | Dishevelled Proteins | 1 | 2015 | 4 | 0.120 |
Why?
| | Child, Preschool | 2 | 2021 | 11080 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 858 | 0.110 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 58 | 0.110 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2015 | 133 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 467 | 0.110 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2013 | 46 | 0.110 |
Why?
| | Fluoxetine | 1 | 2013 | 54 | 0.100 |
Why?
| | Wnt Signaling Pathway | 1 | 2015 | 192 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2013 | 185 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2016 | 769 | 0.090 |
Why?
| | Aging | 1 | 2022 | 1864 | 0.090 |
Why?
| | Female | 5 | 2024 | 73052 | 0.090 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 188 | 0.090 |
Why?
| | Adolescent | 2 | 2021 | 21499 | 0.090 |
Why?
| | Histones | 1 | 2016 | 636 | 0.090 |
Why?
| | Analgesics, Opioid | 2 | 2019 | 994 | 0.090 |
Why?
| | Depressive Disorder | 1 | 2013 | 380 | 0.080 |
Why?
| | Depression | 2 | 2019 | 1408 | 0.080 |
Why?
| | Cell Communication | 1 | 2025 | 315 | 0.050 |
Why?
| | Young Adult | 1 | 2019 | 13163 | 0.050 |
Why?
| | Mice | 5 | 2019 | 17774 | 0.050 |
Why?
| | Whole Genome Sequencing | 1 | 2022 | 153 | 0.050 |
Why?
| | Tissue Banks | 1 | 2021 | 16 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2022 | 190 | 0.040 |
Why?
| | Motor Activity | 2 | 2017 | 719 | 0.040 |
Why?
| | Autopsy | 1 | 2021 | 94 | 0.040 |
Why?
| | Brain Chemistry | 1 | 2021 | 118 | 0.040 |
Why?
| | Computational Biology | 1 | 2025 | 646 | 0.040 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2021 | 62 | 0.040 |
Why?
| | Adult | 2 | 2021 | 37724 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 2486 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 172 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5726 | 0.040 |
Why?
| | Receptors, Opioid, delta | 1 | 2019 | 10 | 0.040 |
Why?
| | Transcriptome | 1 | 2025 | 972 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 521 | 0.040 |
Why?
| | Benzamides | 1 | 2019 | 217 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 348 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1774 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2025 | 1987 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2839 | 0.030 |
Why?
| | Rats | 2 | 2016 | 5639 | 0.030 |
Why?
| | Piperazines | 1 | 2019 | 350 | 0.030 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2016 | 27 | 0.030 |
Why?
| | Conditioning, Classical | 1 | 2017 | 102 | 0.030 |
Why?
| | Receptors, Dopamine D1 | 1 | 2016 | 34 | 0.030 |
Why?
| | Protein Binding | 1 | 2022 | 2225 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 231 | 0.030 |
Why?
| | Receptors, Dopamine D2 | 1 | 2016 | 98 | 0.030 |
Why?
| | Acetylation | 1 | 2016 | 248 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1923 | 0.030 |
Why?
| | Postmortem Changes | 1 | 2015 | 17 | 0.030 |
Why?
| | Nucleosomes | 1 | 2017 | 155 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2015 | 51 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2015 | 59 | 0.030 |
Why?
| | Heroin Dependence | 1 | 2015 | 33 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2015 | 100 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2015 | 67 | 0.030 |
Why?
| | Sex Factors | 1 | 2020 | 2073 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2022 | 2608 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3546 | 0.020 |
Why?
| | RNA Polymerase II | 1 | 2015 | 324 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3439 | 0.020 |
Why?
| | Social Behavior | 1 | 2013 | 287 | 0.020 |
Why?
| | Mutation | 1 | 2022 | 3956 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2164 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1250 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4284 | 0.020 |
Why?
| | Middle Aged | 1 | 2013 | 33310 | 0.010 |
Why?
|
|
Dias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|